Prevalence of depression among children, adolescents, and adults with hidradenitis suppurativa

Hoffman, 2017, Major gaps in understanding and treatment of hidradenitis suppurativa, Semin Cutan Med Surg, 36, 86, 10.12788/j.sder.2017.024 Garg, 2020, Evaluating patients' unmet needs in hidradenitis suppurativa: results from the Global Survey of Impact and Healthcare Needs (VOICE) project, J Am Acad Dermatol, 82, 366, 10.1016/j.jaad.2019.06.1301 Gooderham, 2015, The psychosocial impact of hidradenitis suppurativa, J Am Acad Dermatol, 73, S19, 10.1016/j.jaad.2015.07.054 MacMahon, 2020, An update on health-related quality of life and patient-reported outcomes in hidradenitis suppurativa, Patient Relat Outcome Meas, 11, 21, 10.2147/PROM.S174299 Wright, 2020, New-onset depression among children, adolescents, and adults with hidradenitis suppurativa, J Am Acad Dermatol, 83, 1360, 10.1016/j.jaad.2020.05.090 SNOMED CT McDonald, 2003, LOINC, a universal standard for identifying laboratory observations: a 5-year update, Clin Chem, 49, 624, 10.1373/49.4.624 Nelson, 2011, Normalized names for clinical drugs: RxNorm at 6 years, J Am Med Inform Assoc, 18, 441, 10.1136/amiajnl-2011-000116 Rassen, 2019, Measuring prevalence and incidence of chronic conditions in claims and electronic health record databases, Clin Epidemiol, 11, 1, 10.2147/CLEP.S181242 Strunk, 2017, Validation of a case-finding algorithm for hidradenitis suppurativa using administrative coding from a clinical database, Dermatology, 233, 53, 10.1159/000468148 Fiest, 2014, Systematic review and assessment of validated case definitions for depression in administrative data, BMC Psychiatry, 14, 289, 10.1186/s12888-014-0289-5 Van Buuren, 2011, mice: multivariate imputation by chained equations in R, J Stat Softw, 45, 1 Matusiak, 2009, Increased serum tumour necrosis factor-α in hidradenitis suppurativa patients: is there a basis for treatment with anti-tumour necrosis factor-α agents?, Acta Derm Venereol, 89, 601, 10.2340/00015555-0749 Matusiak, 2017, Increased interleukin (IL)-17 serum levels in patients with hidradenitis suppurativa: implications for treatment with anti-IL-17 agents, J Am Acad Dermatol, 76, 670, 10.1016/j.jaad.2016.10.042 Xu, 2017, Increased serum interleukin-6 levels in patients with hidradenitis suppurativa, Postepy Dermatol Alergol, 34, 82, 10.5114/ada.2017.65626 Jiménez-Gallo, 2017, The clinical significance of increased serum proinflammatory cytokines, C-reactive protein, and erythrocyte sedimentation rate in patients with hidradenitis suppurativa, Mediators Inflamm, 2017, 2450401, 10.1155/2017/2450401 Farzanfar, 2018, Inflammation: a contributor to depressive comorbidity in inflammatory skin disease, Skin Pharmacol Physiol, 31, 246, 10.1159/000490002 Theut Riis, 2019, Prevalence of patients with self-reported hidradenitis suppurativa in a cohort of Danish blood donors: a cross-sectional study, Br J Dematol, 180, 774, 10.1111/bjd.16998 Pavon Blanco, 2019, To what extent do disease severity and illness perceptions explain depression, anxiety and quality of life in hidradenitis suppurativa?, Br J Dermatol, 180, 338, 10.1111/bjd.17123 Butt, 2019, The associations of depression and coping methods on health-related quality of life for those with hidradenitis suppurativa, J Am Acad Dermatol, 80, 1137, 10.1016/j.jaad.2018.09.045 Kirby, 2017, Association of resilience with depression and health-related quality of life for patients with hidradenitis suppurativa, JAMA Dermatol, 153, 1263, 10.1001/jamadermatol.2017.3596 Onderdijk, 2013, Depression in patients with hidradenitis suppurativa, J Eur Acad Dermatol Venereol, 27, 473, 10.1111/j.1468-3083.2012.04468.x Senthilnathan, 2019, Depression in hidradenitis suppurativa, Br J Dermatol, 181, 1087, 10.1111/bjd.18132 Crowley, 2014, Association of hidradenitis suppurativa disease severity with increased risk for systemic comorbidities, Br J Dermatol, 171, 1561, 10.1111/bjd.13122 Kurek, 2013, Depression is a frequent co-morbidity in patients with acne inversa, J Dtsch Dermatol Ges, 11, 743 Matusiak, 2010, Psychophysical aspects of hidradenitis suppurativa, Acta Derm Venerol, 90, 264, 10.2340/00015555-0866 Wright, 2020, Trends in body mass index before and after diagnosis of hidradenitis suppurativa, Br J Dermatol Balgobind, 2020, Association between obesity and hidradenitis suppurativa among children and adolescents: a population-based analysis in the United States, J Am Acad Dermatol, 82, 502, 10.1016/j.jaad.2019.08.034 Garg, 2018, Incidence of hidradenitis suppurativa among tobacco smokers: a population-based retrospective analysis in the U.S.A, Br J Dermatol, 178, 709, 10.1111/bjd.15939 Garg, 2018, Opioid, alcohol, and cannabis misuse among patients with hidradenitis suppurativa: a population-based analysis in the United States, J Am Acad Dermatol, 79, 495, 10.1016/j.jaad.2018.02.053 Reddy, 2019, Incidence of long-term opioid use among opioid-naive patients with hidradenitis suppurativa in the United States, JAMA Dermatol, 155, 1284, 10.1001/jamadermatol.2019.2610 Vazquez, 2013, Incidence of hidradenitis suppurativa and associated factors: a population-based study of Olmsted County, Minnesota, J Invest Dermatol, 133, 97, 10.1038/jid.2012.255 Patel, 2019, Association between hidradenitis suppurativa and hospitalization for psychiatric disorders: a cross-sectional analysis of the National Inpatient Sample, Br J Dermatol, 181, 275, 10.1111/bjd.17416 Brody, 2018, Prevalence of depression among adults aged 20 and over: United States, 2013-2016, NCHS Data Brief, 303, 1 Ellervik, 2014, Prevalence of depression, quality of life and antidepressant treatment in the Danish General Suburban Population Study, Nord J Psychiatry, 68, 507, 10.3109/08039488.2013.877074 Smith, 2013, Prevalence and characteristics of probable major depression and bipolar disorder within UK Biobank: cross-sectional study of 172,751 participants, PLoS One, 8, e75362, 10.1371/journal.pone.0075362 Markkula, 2015, Prevalence and correlates of major depressive disorder and dysthymia in an eleven-year follow-up - results from the Finnish Health 2011 Survey, J Affect Disord, 173, 73, 10.1016/j.jad.2014.10.015 Thorlacius, 2018, Increased suicide risk in patients with hidradenitis suppurativa, J Invest Dermatol, 138, 52, 10.1016/j.jid.2017.09.008 Ingram, 2018, Population-based clinical practice research datalink study using algorithm modelling to identify the true burden of hidradenitis suppurativa, Br J Dermatol, 178, 917, 10.1111/bjd.16101 Huilaja, 2018, Patients with hidradenitis suppurativa have a high psychiatric disease burden: a Finnish nationwide registry study, J Invest Dermatol, 138, 46, 10.1016/j.jid.2017.06.020 Tiri, 2018, Somatic and psychiatric comorbidities of hidradenitis suppurativa in children and adolescents, J Am Acad Dermatol, 79, 514, 10.1016/j.jaad.2018.02.067 Garg, 2021, Comorbidity screening in hidradenitis suppurativa: evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations, J Am Acad Dermatol, 10.1016/j.jaad.2021.01.059